Phase Ii evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study
Stehman, F.B.; Blessing, J.A.; Delgado, G.; Louka, M.
Cancer Treatment Reports 67(7-8): 737-738
1983
ISSN/ISBN: 0361-5960 PMID: 6871892 Document Number: 205858
Document emailed within 1 workday
Related Documents
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528Zaino, R.J. 1995: Pathologic indicators of prognosis in endometrial adenocarcinoma. Selected aspects emphasizing the GOG experience. Gynecologic Oncology Group Pathology Annual 30: 1-28
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Slavik, M.; Muss, H.; Blessing, J.A.; Delgado, G. 1982: Phase Ii clinical study of Yoshi 864 in epithelial ovarian carcinoma: a Gynecologic Oncology Group Study Cancer Treatment Reports 66(9): 1775-1777
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Cirpan, T.; Terek, M.C.; Mgoyi, L.; Zekioglu, O.; Iscan, O.; Ozsaran, A. 2006: Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium European Journal of Gynaecological Oncology 27(4): 389-392
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Moertel, C.G.; Lavin, P.T. 1979: Phase II-IIi chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group Cancer Treatment Reports 63(11-12): 1863-1869
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Hilgers, R.D.; Von Hoff, D.D.; Stephens, R.L.; Boutselis, J.G.; Rivkin, S.E. 1985: Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study Cancer Treatment Reports 69(11): 1329-1330
Hakes, T.B.; Raymond, V. 1987: Phase Ii study of idarubicin in advanced endometrial carcinoma Cancer Treatment Reports 71(5): 535-536
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618
Lovecchio, J.L.; Averette, H.E.; Lichtinger, M.; Townsend, P.A.; Girtanner, R.W.; Fenton, A.N. 1984: Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate Obstetrics and Gynecology 63(4): 557-560
Wiltshaw, E.; Kroner, T. 1976: Phase Ii study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary Cancer Treatment Reports 60(1): 55-60
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22